Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Buy
16,866
+1,982
+13% +$51.8K 0.01% 249
2026
Q1
$418K Buy
14,884
+2,416
+19% +$64.3K 0.01% 196
2025
Q4
$322K Buy
+12,468
New +$314K 0.01% 212

Other funds holding PFE

Facet Wealth Inc's PFE Position: Q2 2026 in Review

Facet Wealth Inc increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $51.8K and bringing the position to 16,866 shares worth $406K. The position accounts for 0.01% of the portfolio, ranked #249.

Facet Wealth Inc first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $418K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Facet Wealth Inc held 16,866 shares of Pfizer worth $406K as of Q2 2026.
  • Facet Wealth Inc bought 1,982 Pfizer shares in Q2 2026, an estimated $51.8K.
  • Pfizer made up 0.01% of Facet Wealth Inc's portfolio in Q2 2026, its #249 holding.
  • Facet Wealth Inc first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Facet Wealth Inc's Pfizer position peaked at $418K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Facet Wealth Inc's 13F filing for Q2 2026, filed 27 Jul 2026.